Glaxo Smith Kline (GSK) announced in May that Flovent HFA, a metered-dose inhaler, as well as Flovent Diskus, a dry powder inhaler, would be discontinued as of Dec. 31, 2023. Experts shared comment.

Flovent, one of the most commonly prescribed asthma medications, is no longer being manufactured. Parents share their thoughts on alternatives. Hotspots ranked Start the day smarter ☀️ ...

Nebulizers and inhalers are used to deliver medications for asthma and COPD. While both are effective, improper inhaler techniques can prevent you from getting the right amount of medication. If ...

Respiratory Inhalers Patent Landscape Market Respiratory Inhalers Patent Landscape Market Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Respiratory Inhalers Patent Landscape Report and Forecast ...

Maintaining a respiratory-friendly lifestyle is essential. • Is not the inhaler a module for adults? The inhaler is only a method of drug use. Medication dosages for children are closely adhered to.

Lower respiratory infections can also be treated at home with rest, fluids, and over-the-counter medications. In addition, you may need a bronchodilator inhaler if you are wheezing and short of ...

The respiratory inhaler devices market is a critical component of the global healthcare industry, focusing on devices designed to deliver medication directly to the lungs to treat respiratory diseases ...

The global respiratory inhaler devices market is on the cusp of significant transformation over the next decade, driven by a rising incidence of respiratory diseases, technological advancements, and ...

Expert opinion from Dr. Anuvitha Kamath MBBS · 3 years of experience · India. S ome of the practices for prevention of ...

Respiratory Inhalers Patent Landscape Market Respiratory Inhalers Patent Landscape Market Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Respiratory Inhalers Patent Landscape Report and Forecast 2024 ...

Respiratory Inhalers Patent Landscape Market Respiratory Inhalers Patent Landscape Market Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Respiratory Inhalers Patent Landscape Report and Forecast 2024 ...